ace

Documents about ace

• Effect of Bradykinin Receptor Antagonism on ACE Inhibitor-associated Angioedema#158070ClinicalTrials.gov
• Team-ACE/ToolACE#786808Hugging Face Datasets
• The COMFORTage Project at Ace Alzheimer Center Barcelona#994831ClinicalTrials.gov
• Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis#966156ClinicalTrials.gov
• Pharmacogenetics of Ace Inhibitor-Associated Angioedema#854932ClinicalTrials.gov
• Clinical and Cost Effectiveness of ACE Inhibitor, Ramipril, in Intermittent Claudicants#869073ClinicalTrials.gov
• ACE I/D genotype in professional field hockey players#964110ISUDR
• Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia#854646ClinicalTrials.gov
• A Bioequivalence Study Between Capozide Versus ACE-Hemmer-ratiopharm in Healthy Adult Participants Under Fasting Conditions#968084ClinicalTrials.gov
• Littlewood and the Paradox of the Second Ace#106345PhilArchive
• Therapy code list - ACE inhibitors#206177LSHTM Data Compass
• crucifix as war trophy, Shakespeare as Ace Face#697785PhilArchive
• Agape-Centered Ethics (ACE): Practical Application (EC v2.4)#109429PhilArchive
• Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema#154779ClinicalTrials.gov
• Effect of ACE Genotype on Cardiovascular Rehabilitation#640459ClinicalTrials.gov
• Agape-Centered Ethics (ACE): Practical Application (EC v2.7)#687688PhilArchive
• Influence of Angiotensin Converting Enzyme (ACE) Genotype on Lung Diffusion in Heart Failure#850659ClinicalTrials.gov
• A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfusions Due to Beta (β)-Thalassemia.#915063ClinicalTrials.gov
• ACE Inhibitors Combined With Exercise for Seniors - Pilot Study#18752ClinicalTrials.gov
• Ace glicemie universale#294402EU Publications
• Data Quality Flags for ACE-FTS Level 2 Version 5.3 Data Set#272202Borealis Dataverse OAI Archive
• Design and methodology of the AI-empowered Clinical Evidence for Integrated Chinese-Western Medicine (ACE-iMed) platform#304187Europe PMC
• Additional OAuth Parameters for Authentication and Authorization for Constrained Environments (ACE)#243904IETF RFCs
• Cloud Ace Journeys: The Analyst Flight PlanWhitepaperCloud Security18 Jun 2026SANS Institute#293070SANS Institute Reading Room
• Safety & Efficacy of the Laser Scleral Microporation Procedure#829702ClinicalTrials.gov
• MEV-ACE: Identity-Authenticated Fair Ordering for Proposer-Controlled MEV Mitigation#2461arXiv CS
• MEASUREMENT OF WAVE ELEVATION USING PIEZO-ELECTRIC HYDROPHONE#200244Digital Commons @ Michigan Tech
• Ace punctie bioptica diferite dimensiuni#284009EU Publications
• ACE: Adaptive Calibration-Free Expert Skipping for MoE-based LLMs#660867arXiv CS
• Racial Variation in ACE--Genetic and Physiologic Bases#918758ClinicalTrials.gov
• ACE: Adaptive Calibration-Free Expert Skipping for MoE-based LLMs#972167arXiv (All)
• Key Provisioning for Group Communication Using Authentication and Authorization for Constrained Environments (ACE)#133441IETF RFCs
• Ace de seringa UF G 16#234945EU Publications
• Ace de seringa UF G 30#241927EU Publications
• An Authorization Information Format (AIF) for Authentication and Authorization for Constrained Environments (ACE)#502618IETF RFCs
• Enabling Telecommunication Relay Service Research with ACE Omni Platform#609022arXiv (OAI Expanded)
• Enabling Telecommunication Relay Service Research with ACE Omni Platform#610084arXiv (All)
• Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients#908180ClinicalTrials.gov
• Authentication and Authorization for Constrained Environments Using the OAuth 2.0 Framework (ACE-OAuth)#131526IETF RFCs
• Datagram Transport Layer Security (DTLS) Profile for Authentication and Authorization for Constrained Environments (ACE)#213529IETF RFCs
• Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy#901166ClinicalTrials.gov
• A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes#968551ClinicalTrials.gov
• Agape-Centered Ethics: A Naturalistic Framework Grounded in Vicarious Aversion (Short Running Title): The ACE model#73913PhilArchive
• Notification of Revoked Access Tokens in the Authentication and Authorization for Constrained Environments (ACE) Framework#134757IETF RFCs
• Ace anestezie plexala ( Stimuplex ultra 360º, 20 G )#294396EU Publications
• Cateter cu camera implantabila si ace pentru camera#298469EU Publications
• Agape-Centered Ethics: A Naturalistic Framework Grounded in Vicarious Aversion (Short Running Title): The ACE model#716396PhilArchive
• An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low or Intermediate Risk Myelodysplastic Syndromes (MDS) in Japanese Subjects Who Are Not Requiring Red Blood Cell Transfusion#829220ClinicalTrials.gov
• Recalibrating stress regulation through mindfulness: a framework for adapting interventions for ACE-affected populations.#138495NCBI PubMed Central
• ACE Autobody v Motorpark Ltd & ors (Unapproved) [2026] IESC 9 (18 February 2026)#184294BAILII Ireland